Obervational, prospective study to evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan

Trial Profile

Obervational, prospective study to evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2007

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Psychotic disorders
  • Focus Therapeutic Use
  • Sponsors Genovate Biotechnology
  • Most Recent Events

    • 19 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top